• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Device Problem Microbial Contamination of Device (2303)
Patient Problem Bacterial Infection (1735)
Event Date 06/01/2019
Event Type  Injury  
Manufacturer Narrative
Due to an unknown lot/serial number and no device return, an investigation could not be performed.
 
Event Description
The literature article: ¿(moraxella catarrhalis bacteremia associated with lower extremity bypass graft infection)¿ published by (travis sullivan) was reviewed.The article was published online or accepted on (june-1-2019).The use of (gore® propaten® vascular graft) was evaluated for ( redo right common femoral to below knee popliteal bypass).The article was a single case study of a (b)(6) year-old caucasian man right common femoral to below knee popliteal bypass with gore® propaten® vascular graft.Article states that patient presented two weeks post operatively with right lower extremity edema, surgical incision drainage, and fever.Cultures grew gram-negative rods and was later suspected to be morazella catarrhalis.The patient was taken to the operating room and the gore device was explanted.After discussion with the product specialist this article is a reportable event.
 
Manufacturer Narrative
The literature article: ¿(moraxella catarrhalis bacteremia associated with lower extremity bypass graft infection)¿ published by (travis sullivan) was reviewed.The article was published online or accepted on ((b)(6) 2019).The use of (gore® propaten® vascular graft) was evaluated for ( redo right common femoral to below knee popliteal bypass).The article was a single case study of a 64-year-old caucasian man right common femoral to below knee popliteal bypass with gore® propaten® vascular graft.Article states that patient presented two weeks post operatively with right lower extremity edema, surgical incision drainage, and fever.Cultures grew gram-negative rods and was later suspected to be morazella catarrhalis.The patient was taken to the operating room and the gore device was explanted.
 
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key12246771
MDR Text Key264106065
Report Number2017233-2021-02203
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup,Followup
Report Date 09/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received07/12/2021
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age64 YR
-
-